EGFR and non-small cell lung carcinoma: For this reason, Kim et al. [79] used a PNA-clamped PCR method to study EGFR mutations in cfDNA isolated from plasma samples from 60 patients with NSCLC who had shown a partial response to treatment with gefitinib.